Patient-derived organoids as a potential model to predict response to PD-1/PD-L1 checkpoint inhibitors.
Scognamiglio G, De Chiara A, Parafioriti A, Armiraglio E, Fazioli F, Gallo M, Aversa L, Camerlingo R, Cacciatore F, Colella G, Pili R, de Nigris F.
Scognamiglio G, et al. Among authors: colella g.
Br J Cancer. 2019 Nov;121(11):979-982. doi: 10.1038/s41416-019-0616-1. Epub 2019 Oct 31.
Br J Cancer. 2019.
PMID: 31666667
Free PMC article.